Differences in CMV-Specific T-Cell Levels and Long-Term Susceptibility to CMV Infection after Kidney, Heart and Lung Transplantation
Open Access
- 18 April 2005
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 5 (6) , 1483-1489
- https://doi.org/10.1111/j.1600-6143.2005.00871.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Cytomegalovirus and Lung TransplantationAmerican Journal of Transplantation, 2004
- Cyclosporine pharmacokinetics and dose monitoring after lung transplantation: comparison between cystic fibrosis and other conditionsTransplantation, 2003
- Blood cyclosporine C0 and C2 concentrations and cytomegalovirus infections following lung transplantationTransplantation Proceedings, 2003
- Dominance of Virus-Specific CD8 T Cells in Human Primary Cytomegalovirus InfectionJournal of the American Society of Nephrology, 2002
- Infusion of cytomegalovirus (CMV)–specific T cells for the treatment of CMV infection not responding to antiviral chemotherapyBlood, 2002
- Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal TransplantationNew England Journal of Medicine, 1999
- Antiviral DrugsNew England Journal of Medicine, 1999
- Infection in Organ-Transplant RecipientsNew England Journal of Medicine, 1998
- Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the DonorNew England Journal of Medicine, 1995
- Sequelae of Cytomegalovirus Pulmonary Infections in Lung Allograft RecipientsAmerican Review of Respiratory Disease, 1992